|  Help  |  About  |  Contact Us

Publication : Hypoxic retinal Muller cells promote vascular permeability by HIF-1-dependent up-regulation of angiopoietin-like 4.

First Author  Xin X Year  2013
Journal  Proc Natl Acad Sci U S A Volume  110
Issue  36 Pages  E3425-34
PubMed ID  23959876 Mgi Jnum  J:200973
Mgi Id  MGI:5510598 Doi  10.1073/pnas.1217091110
Citation  Xin X, et al. (2013) Hypoxic retinal Muller cells promote vascular permeability by HIF-1-dependent up-regulation of angiopoietin-like 4. Proc Natl Acad Sci U S A 110(36):E3425-34
abstractText  Vision loss from ischemic retinopathies commonly results from the accumulation of fluid in the inner retina [macular edema (ME)]. Although the precise events that lead to the development of ME remain under debate, growing evidence supports a role for an ischemia-induced hyperpermeability state regulated, in part, by VEGF. Monthly treatment with anti-VEGF therapies is effective for the treatment of ME but results in a major improvement in vision in a minority of patients, underscoring the need to identify additional therapeutic targets. Using the oxygen-induced retinopathy mouse model for ischemic retinopathy, we provide evidence showing that hypoxic Muller cells promote vascular permeability by stabilizing hypoxia-inducible factor-1alpha (HIF-1alpha) and secreting angiogenic cytokines. Blocking HIF-1alpha translation with digoxin inhibits the promotion of endothelial cell permeability in vitro and retinal edema in vivo. Interestingly, Muller cells require HIF-but not VEGF-to promote vascular permeability, suggesting that other HIF-dependent factors may contribute to the development of ME. Using gene expression analysis, we identify angiopoietin-like 4 (ANGPTL4) as a cytokine up-regulated by HIF-1 in hypoxic Muller cells in vitro and the ischemic inner retina in vivo. ANGPTL4 is critical and sufficient to promote vessel permeability by hypoxic Muller cells. Immunohistochemical analysis of retinal tissue from patients with diabetic eye disease shows that HIF-1alpha and ANGPTL4 localize to ischemic Muller cells. Our results suggest that ANGPTL4 may play an important role in promoting vessel permeability in ischemic retinopathies and could be an important target for the treatment of ME.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

Trail: Publication

0 Expression